60 related articles for article (PubMed ID: 24528044)
1. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
[TBL] [Abstract][Full Text] [Related]
2. Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol.
Songserm N; Promthet S; Pientong C; Ekalaksananan T; Chopjitt P; Wiangnon S
BMJ Open; 2014 Oct; 4(10):e005447. PubMed ID: 25335960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of p53 and Its Target Gene Expression as Potential Biomarkers of Cholangiocarcinoma in Thai Patients.
Puetkasichonpasutha J; Namwat N; Sa-Ngiamwibool P; Titapun A; Suthiphongchai T
Asian Pac J Cancer Prev; 2020 Mar; 21(3):791-798. PubMed ID: 32212809
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China.
Xu X; Sun J; Chang X; Wang J; Luo M; Wintergerst KA; Miao L; Cai L
J Cell Mol Med; 2016 Nov; 20(11):2078-2088. PubMed ID: 27374075
[TBL] [Abstract][Full Text] [Related]
5. CpG-island methylation study of liver fluke-related cholangiocarcinoma.
Sriraksa R; Zeller C; El-Bahrawy MA; Dai W; Daduang J; Jearanaikoon P; Chau-In S; Brown R; Limpaiboon T
Br J Cancer; 2011 Apr; 104(8):1313-8. PubMed ID: 21448164
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study.
Zhang C; You X; Zhang Q; Wang D
Invest New Drugs; 2024 Feb; 42(1):24-34. PubMed ID: 37975978
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.
Chuensumran U; Wongkham S; Pairojkul C; Chauin S; Petmitr S
World J Gastroenterol; 2007 Jun; 13(21):2986-91. PubMed ID: 17589952
[TBL] [Abstract][Full Text] [Related]
8. A transcriptome based molecular classification scheme for cholangiocarcinoma and subtype-derived prognostic biomarker.
Fan Z; Zou X; Wang G; Liu Y; Jiang Y; Wang H; Zhang P; Wei F; Du X; Wang M; Sun X; Ji B; Hu X; Chen L; Zhou P; Wang D; Bai J; Xiao X; Zuo L; Xia X; Yi X; Lv G
Nat Commun; 2024 Jan; 15(1):484. PubMed ID: 38212331
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study.
Zhu XX; Li JH; Fang P; Qu XF; Liang LJ; Lai JM; Yin XY
BMC Cancer; 2023 Sep; 23(1):826. PubMed ID: 37670280
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in the Promoter Region of NFE2L2 Gene Is a Genetic Marker of Susceptibility to Cirrhosis Associated with Alcohol Abuse.
Nunes Dos Santos K; Florentino RM; França A; Lima Filho ACM; Santos MLD; Missiaggia D; Fonseca MC; Brasil Costa I; Vidigal PVT; Nathanson MH; Lemos FO; Leite MF
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340446
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic molecular markers for cholangiocarcinoma in Han Chinese population.
Meng L; Tian Z; Wang Y; Liu Y; Liu J
Int J Clin Exp Med; 2015; 8(8):13680-9. PubMed ID: 26550313
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.
Proungvitaya S; Sombattheera S; Boonsiri P; Limpaiboon T; Wongkham S; Wongkham C; Titapun A; Proungvitaya T
Oncol Lett; 2017 Oct; 14(4):4943-4948. PubMed ID: 29085505
[TBL] [Abstract][Full Text] [Related]
13. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan V
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):601-12. PubMed ID: 25708948
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of Nrf2, an antioxidative gene, are associated with blood pressure in Japanese.
Shimoyama Y; Mitsuda Y; Hamajima N; Niwa T
Nagoya J Med Sci; 2014 Feb; 76(1-2):113-20. PubMed ID: 25129997
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.
Reszka E; Jablonowski Z; Wieczorek E; Jablonska E; Krol MB; Gromadzinska J; Grzegorczyk A; Sosnowski M; Wasowicz W
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1723-31. PubMed ID: 24919441
[TBL] [Abstract][Full Text] [Related]
16. Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival.
Gong R; Qiu M; Cao J; Zhou Z; Wei Y; Wen Q; Lin Q; Wei X; Liang X; Jiang Y; Chen P; Wei J; Zhan S; Liu Y; Yu H
J Cancer; 2023; 14(18):3387-3396. PubMed ID: 38021150
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants-related nuclear factor erythroid 2-related factor 2 gene variants associated with HBV-related liver disease.
Liu Y; Wu Q; Zhang F; Qin X
Cancer Cell Int; 2023 Apr; 23(1):72. PubMed ID: 37062839
[TBL] [Abstract][Full Text] [Related]
18. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review.
Wang G; Heij LR; Liu D; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497451
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.
Pavicevic S; Reichelt S; Uluk D; Lurje I; Engelmann C; Modest DP; Pelzer U; Krenzien F; Raschzok N; Benzing C; Sauer IM; Stintzing S; Tacke F; Schöning W; Schmelzle M; Pratschke J; Lurje G
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205774
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine.
Malenica I; Donadon M; Lleo A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
